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ABSTRACT 
BIOFILM GENETICS OF BURKHOLDERIA CENOCEPACIA 
By 
Laura C. Benton 
University of New Hampshire, December 2009 
Burkholderia cenocepacia is a soil bacterium and opportunistic human pathogen 
found to infect the lungs of cystic fibrosis (CF) patients. One factor that may allow B. 
cenocepacia to persist in the CF lung and continue to cause a decline in lung function is 
its ability to form biofilms. Little is known about the genetic mechanisms allowing this 
bacterium to transition from an acute to a chronic (biofilm) lifestyle. I used both 
transposon mutagenesis and positive laboratory selection to identify mutations that 
increase biofilm production. Mutations affecting capsule polysaccharide synthesis were 
identified, among others, by random mutagenesis to confer an increased biofilm 
phenotype, whereas mutations putatively resulting in increased intracellular levels of 




The Transition from Acute to Chronic Infections 
A phenomenon that occurs in cystic fibrosis (CF) lung infections is a transition of 
the infecting bacteria from a lifestyle associated with an acute infection to one 
associated with a chronic infection. An acute infection is more likely to be cleared by 
aggressive antibiotic therapy than a chronic infection associated with establishment of 
persistent biofilm (Hoiby et al., 2005). It has been proposed that the transition involves 
a series of key adaptive mutations in genes that govern these two lifestyles (Furukawa 
et al., 2006) and that the evolution of bacterial populations in the CF lung follows a 
predictable, repeated pattern (D'Argenio et al., 2007). Identifying the pattern of 
molecular changes that occurs in bacteria establishing a chronic, biofilm-forming 
lifestyle is crucial for developing methods to control such infections by preventing the 
switch from acute to chronic stages. 
Biofilms 
A biofilm is a complex community of bacteria anchored to a living or inert surface 
and protected from the 'outside world' by a secreted extracellular matrix of complex 
sugars, proteins, lipids, nucleic acids and decaying cell debris (reviewed by Vu et al., 
2009). Biofilms can form on surfaces ranging from the inside of plumbing pipes to the 
surface of our heart valves (endocarditis). In medicine, biofilms forming on surfaces 
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such as catheters and open wounds are especially worrisome since they lead to 
infections that are increasingly resistant to antibiotics and can often evade our immune 
system (Donlan, 2001). Since infections caused by bacteria forming biofilms are so 
difficult to clear from patients, many produce chronic infections that may become fatal 
(Furukawa et al., 2006; Cunha et al., 2004). One such bacterium associated with a poor 
prognosis when causing biofilm-related infections is Burkholderia cenocepacia, the 
model organism for my studies. 
The Burkholderia cepacia complex 
B. cenocepacia is a soil bacterium and opportunistic pathogen of the Burkholderia 
cepacia complex (Bcc). The Bcc is comprised of at least 17 species, most of which have 
been found to infect the lungs of CF patients (Springman et al., 2009). These lung 
infections can lead to 'cepacia syndrome', characterized by necrotizing pneumonia and 
septicemia (Mahenthiralingam et al., 2008). Bcc-positive CF patients may be removed 
from lung transplant lists in lung transplant centers (Alexander et al., 2008) and 
commonly cohorted or segregated from the rest of the CF community to prevent 
contagious spread (Lynch, 2009). Previous infection with B. cenocepacia, specifically, 
correlates with a higher rate of death post-transplant than other members of the Bcc or 
other infecting bacteria in CF patients receiving a lung transplant (Alexander et al., 
2008). In addition to its high correlation with infection and post-transplant fatality, this 
species is important to the CF community because it has a nearly 50% prevalence in Bcc 
CF lung infections and is frequently acquired from environmental reservoirs 
(Mahenthiralingam et al., 2005; 2008). 
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An important virulence determinant of B. cenocepacia in the CF lung may be the 
ability to form a persistent biofilm (Moreau-Marquis et al., 2008; Savoia and Zucca, 
2007; Romanova lu et al., 2009). Previous work to identify genes controlling biofilm 
formation in B. cenocepacia has mainly involved screens for mutants defective in biofilm 
formation among transposon mutants (Huber et al., 2001; 2002; Tomlin et al., 2005; 
Ferreira et al., 2007). Another strategy to identify biofilm genes has involved the use of 
comparative genomics between B. cenocepacia and the CF pathogen P. aeruginosa to 
identify well-characterized biofilm gene homologs and subsequently manipulate them in 
the B. cenocepacia background (Saldias et al., 2008; Aubert et al., 2008). Though these 
genes may have important roles in the ability to form biofilms, there is still much to be 
discovered and characterized in B. cenocepacia, especially in defining the relative 
importance of these genes for biofilm production. 
Genetic Control of Biofilm Production in B. cenocepacia 
A variety of approaches have identified biofilm genes in the CF lung pathogen 
Pseudomonas aeruginosa but the genes that control biofilm production in B. 
cenocepacia are less well known. The sigma factor, RpoN, is known to control biofilm in 
P. aeruginosa (Boucher et al., 2000), and Saldias et al. (2008) identified its homolog in B. 
cenocepacia J2315. When inactivated by a transposon insertion, the rpoN homolog in 6. 
cenocepacia K56-2 reduced biofilm production by 40%. The RetS protein in P. 
aeruginosa also controls biofilm formation (Goodman et al., 2004). Aubert et al. (2008) 
identified a Pseudomonas RetS homolog called AtsR in B. cenocepacia J2315, which they 
knocked out in B. cenocepacia K56-2, resulting in a 50% increase in biofilm yield. 
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The majority of known biofilm genes have been identified through random 
mutagenesis. For example, the genes bceD and bceF were initially identified in a 
random mutagenesis of B. cepacia IST408 and further characterized as genes governing 
exopolysaccharide (EPS) production. Knockouts of bceD and bceF decreased cepacian 
(EPS) production and 48hr biofilm yield (Ferreira et al., 2007). 
Huber et al. (2002) performed a random transposon mutagenesis of B. cenocepacia 
H i l l and identified the genes tolA, bap, recR, yciR, gspE, suhB, rodA and yciL that when 
knocked out exhibited biofilm defects. Two of these genes, gspE and yciR, will be 
discussed later in this thesis. The gspE gene has a putative role in a general secretory 
pathway, perhaps affecting secretion of biofilm components. The yciR gene has a 
putative role in regulating the bacterial second messenger, cyclic-di-GMP, since the 
predicted YciR protein contains both GGDEF and EAL amino acid motifs, which generally 
are found in diguanylate cyclase and phosphodiesterase enzymes, respectively, that 
synthesize or break down this second messenger (reviewed by Tamayo et al., 2007). 
The Role of Cyclic-di-GMP 
Secondary messengers, such as cyclic-di-GMP (Figure 1.1), cyclic-AMP and 
guanosine pentaphosphate (pppGpp) and tetraphosphate (ppGpp), respond to and 
transduce signals from stimuli such as environmental oxygen, light, or intracellular 
changes and cell-cycle signals, turning them into different cellular responses (Pesavento 
and Hengge, 2009). Cyclic-di-GMP is a bacterial secondary messenger widely distributed 
among prokaryotes that was first described as an allosteric activator of cellulose 
synthase in Gluconacetobacter xylinus (Ross et al., 1987). It has since been identified as 
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an important regulator of biofilm formation, motility, and production of virulence 
factors in Pseudomonas aeruginosa, Xanthomonas campestris, and Vibrio cholerae 
(Kulasekara et al., 2005, Lim et al., 2007, Ryan et al., 2006a, Tischler and Camilli, 2005). 
Cyclic-di-GMP also regulates phase changes in V. cholerae f rom 'smooth' to 'rugose,' a 
phenotype that is less susceptible to bacteriophage infection (Beyhan et al., 2007, 
Beyhan and Yildiz, 2007). 
o 
Figure 1.1: Chemical Structure of Cvclic-di-GMP (bis-(3'-5')- cyclic dimeric guanosine 
monophosphate) 
Two enzymes, diguanylate cyclase and phosphodiesterase A, control intracellular 
levels of cyclic-di-GMP by synthesizing and degrading the dinucleotide, respectively. 
These enzymes are proteins with conserved amino acid motifs: a GGDEF motif in 
diguanylate cyclase and EAL or HD-GYP motifs in phosphodiesterase. In hybrid proteins 
with both predicted enzyme functions, the action of the synthesizing GGDEF protein 
domain is often countered by either an EAL or HD-GYP domain that hydrolyzes cyclic-di-
GMP (reviewed by Ryan et al., 2006b; Hengge, 2009). 
In Pseudomonas, as in many other bacteria, intracellular pooling of cyclic-di-GMP 
leads to a sessile, biofilm lifestyle and the absence or decrease of cyclic-di-GMP leads to 
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a more motile lifestyle (Merritt et al., 2007). Increases in cyclic-di-GMP levels in general 
up-regulate or down-regulate different virulence traits of P. aeruginosa (Kulasekara et 
al., 2005). Low levels of cyclic-di-GMP promote acute virulence traits, specifically, in V. 
cholerae (Tamayo et al., 2007). High levels of cyclic-di-GMP in P. aeruginosa, which 
promote a sessile, biofilm lifestyle, may also lead to attenuated acute virulence since a 
mutant resulting in high cyclic-di-GMP levels is impaired in acute virulence (Chung et al., 
2008). 
Quorum sensing in the genus Burkholderia has also been implicated in regulation of 
biofilm formation as well as regulation of virulence factors (Eberl, 2006). The CepIR 
Quorum Sensing (QS) system was identified in screens of random mutants of B. 
cenocepacia H i l l and K56-2 as a two-component regulatory system controlling biofilm 
production (Huber et al., 2001; Tomlin et al. 2005). In the genus Burkholderia, QS 
systems employ /V-acyl-homoserine lactone (AHL) molecules to communicate and 
regulate expression of certain genes in a cell-density dependent manner. In many 
strains of 6. cenocepacia, the QS system is composed of the Cepl/CepR two-component 
system that produces octanoyl homoserine lactone (C8-HSL) as its main AHL, and 
produces hexanoyl homoserine lactone (C6-HSL) to a lesser degree (Eberl 2006). The 
YciR protein identified by Huber et al. (2002) was described as a possible higher-level 
regulator of the CepIR quorum sensing (QS) system based on the results that a yciR 
mutant behaved similarly to a cepR mutant in biofilm defect and loss of QS molecule 
production but could not be complemented with a functional cepR in trans (Huber et al., 
2002). 
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In the CF pathogen P. aeruginosa, some chronic infection-associated mutations 
have been identified from clinical isolates of CF lung infections (Smith et al., 2006), but 
little has been done in B. cenocepacia to identify adaptively relevant biofilm mutations. 
It is clear that Pseudomonas undergoes many genetic changes in transitioning from an 
acute to a chronic infection, often losing the ability to produce acute virulence factors 
(Smith et al., 2006). The common mutations occurring in chronic isolates of P. 
aeruginosa are in lasR (quorum sensing) and mex (multidrug efflux) genes (Smith et alv 
2006). B. cenocepacia may also adapt to the CF lung in a similar manner since the two 
pathogens are in the same selective environment, however the molecular basis of 
biofilm adaptation in members of the Bcc has yet to be identified. 
CF Lung Pathogens Produce Small-Colony Variants (SCVs) or Rugose SCVs (RSCVs) 
Small colony variants (SCVs), or rugose SCVs (RSCVs), recovered from CF patients 
with chronic lung infections support the hypothesis that similar and predictable 
mechanisms of adaptation to a biofilm liefestyle exist between P. aeruginosa and B. 
cenocepacia. Phenotypes of SCVs of Bcc members isolated from chronic CF lung 
infection are similar to those of P. aeruginosa in that these colony variants are highly 
adherent biofilm producers (Haussler et al., 2003; Haussler, 2004). Clinical RSCVs from a i 
CF lung have similar colony and biofilm phenotypes to a laboratory manipulated 
Pseudomonas wspF mutant, which leads to constitutive activation of a diguanylate 
cyclase and results in intracellular pooling of cyclic-di-GMP (D'Argenio et alv 2002). 
Though similar in colony appearance and cell adherence, not all Pseudomonas RSCVs 
(laboratory or clinical isolates) are caused by the same mutations. Indeed, in a study by 
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Starkey et al. (2009), genetic complementation of the Pseudomonas RSCV phenotype 
with a functional wspF gene in trans was successful only in a portion of laboratory 
biofilm derived RSCVs, returning colony morphology and biofilm production to wild-type 
appearance and levels, respectively. In contrast, complementation with a native 
phosphodiesterase was successful in all RSCVs. The clinical RSCV from the same study 
was only complemented with a native phosphodiesterase in trans, which reversed the 
RSCV phenotype to wild-type colony and biofilm production by reducing intracellular 
cyclic-di-GMP pooling. 
In a recent study by Poltak et al. (2009), populations of B. cenocepacia were 
experimentally evolved for about 1500 generations in an environment favoring biofilm 
formation. Each of six replicate populations adapted to the biofilm lifestyle in part by 
production of wrinkly or rugose colony variants, some very similar to RSCVs, that are 
highly adherent hyper-biofilm formers. Control populations selected for planktonic 
growth in similar media did not produce the same variation seen in the biofilm-adapted 
populations nor did they increase their biofilm production. The genomes of three 
colony variants from one population (termed Studded [S], Ruffled Spreader[R] and 
Wrinkly [W]) were fully sequenced and revealed mutations shared by all three variants 
that likely have consequences for iron metabolism, general efflux, and sugar metabolism 
(Poltak et al., 2009). One shared mutation, a yciR deletion, as well as a wspA mutation 
in the W variant and a wspD mutation in the R variant, all have potential for increasing 
intracellular cyclic-di-GMP levels in the adapted mutants. I focus on one of these 
mutations, the yciR deletion, shared by all three evolved isolates from 1500 generations 
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as a potential genetic basis for the RSCV phenotype in biofilm-adapted isolates of B. 
cenocepacia because this mutation likely leads to increased intracellular pooling of 
cyclic-di-GMP through inactivation of a phosphodiesterase . 
Little is known about the specific genetics of the RSCV isolates from chronic 
respiratory infections, but the presence of these biofilm-adapted colony variants results 
in a poorer patient prognosis (Starkey et al., 2009). Starkey et al. (2009) confirmed that 
P. aeruginosa RSCV strains produced elevated concentrations of cyclic-di-GMP, either as 
a consequence of a wspF mutation or due to different but functionally similar 
mutations. Thus, increased intracellular cyclic-di-GMP concentration appears to be the 
cause of the RSCV phenotype in all P. aeruginosa isolates sampled whether they 
originated from a chronic CF lung infection or were produced in the laboratory. The 
same mechanism may also occur in laboratory produced and chronic CF lung isolates of 
B. cenocepacia. 
In the following chapters I present research on the genes involved in biofilm 
production in B. cenocepacia, specifically those that when mutated increase biofilm 
production. My approach to identify these genes is two-fold. First, I study mutants 
created by random transposon mutagenesis that exhibit enhanced biofilm production. 
Second, I study evolved mutants that rose to high frequency in populations selected for 
enhanced biofilm production over ~1500 generations and identify their molecular bases. 
These mutations highlight both the potential mutational paths to increased biofilm 




IDENTIFYING MUTATIONS RESULTING IN INCREASED BIOFILM PRODUCTION 
Introduction 
Bacterial biofilms are commonly difficult to clear from patients with maladies 
ranging from ear infections to chronic lung infections; therefore, a better understanding 
of the mechanisms controlling a persistent biofilm lifestyle is invaluable for treatment. 
Often, the lungs of cystic fibrosis patients become chronically colonized with 
Pseudomonas aeruginosa and, detected in increasing frequency, with members of the 
Burkholderia cepacia complex (Mahenthiralingam et al., 2008). 
Adaptive phenotypes of the CF pathogens, B. cenocepacia and P. aeruginosa, 
produced from biofilm populations include a wide range of colony morphologies, from 
mucoid to wrinkly or rugose, as well as a range of biofilm production and adherence 
abilities (Haussler et al., 2003; Haussler 2004; Poltak et al., 2009; Smith et al., 2009). 
Earlier studies utilizing random mutagenesis identified a handful of structural and 
regulatory genes involved with biofilm formation in B. cenocepacia (Huber et al., 2001; 
2002; Tomlin et al., 2005; Ferreira et al., 2007; Aubert et al., 2008; Saldias et al., 2008) 
but it remains an open question whether these mutations are those that produce the 
adaptive phenotypes seen in bacterial biofilm populations. One critical adaptive 
mechanism leading to increased biofilm formation in Burkholderia may be intracellular 
pooling of cyclic-di-GMP, which has been identified in P. aeruginosa to be responsible 
for both colony morphology change and increased biofilm production. Mutations 
leading to increased intracellular cyclic-di-GMP pooling have been identified both by 
random mutagenesis (Hickman et al., 2005) and by sequencing of lung-adapted isolates 
of P. aeruginosa (Smith et al., 2006). 
The majority of biofilm genes identified to date in B. cenocepacia negatively 
affect biofilm production when inactivated (Saldias et al., 2008; Ferreira et al., 2007; 
Huber et al., 2001 and 2002). However, it is known that mutations occurring in a 
portion of chronic Pseudomonas isolates from CF patients may enhance biofilm 
production (Haussler, 2004). Some of the genetic mechanisms conferring this 
phenotype, often associated with small colony variants (SCVs), are known in 
Pseudomonas (Starkey et al., 2009). Based on the similar Burkholderia clinical SCV 
phenotype of increased biofilm production and strong cell-cell adherence (Haussler et 
al., 2003), I hypothesize that genetic mechanisms leading to increased intracellular 
levels of cyclic-di-GMP are also similar between these two CF pathogens. 
We do not know the possible mutations that improve biofilm production in B. 
cenocepacia, nor do we know which of these possible pathways underlie the adaptation 
that occurs in a biofilm-selective environment such as the CF lung. These gaps in our 
knowledge of B. cenocepacia and how it adapts in chronic infections led me to two 
questions: 
1. What mutations may increase biofilm production in B. cenocepacia? 
2. Of the possible mutations contributing to this phenotype, what fraction improve 
fitness in an environment favoring biofilm production? 
1 1 
To answer the first question, I created a random transposon mutant library and 
screened each mutant for increased biofilm production, possibly selecting mutations in 
genes involved in biofilm regulation. This is the first gain-of-function biofilm screen to 
be performed with B. cenocepacia, though at least one such study was recently 
performed on P. aeruginosa (Ueda and Wood, 2009). Ueda and Wood (2009) described 
tbpA, a tyrosine phosphatase controlling a diguanylate cyclase (tbpB). TbpB is 
overexpressed in the tbpA mutant and leads to increased intracellular levels of cyclic-di-
GMP, increased biofilm, wrinkly colony morphology and decreased motility. I predicted 
that I would find mutations leading to increased intracellular pooling of cyclic-di-GMP 
since this would increase biofilm production. I also expected to find gain-of-function 
biofilm mutations in genes yet to be characterized in B. cenocepacia since the gain-of-
function biofilm screen has not been utilized yet in this organism. 
I wondered how many of the genes identified by my random screens also would 
acquire mutations in an adaptive model of laboratory biofilm evolution. Replicate 
populations of B. cenocepacia HI2424 were evolved in an environment selecting for 
increased biofilm production over 1500 generations and produced colony variants 
resembling RSCV's that also exhibited greatly increased biofilm production (Poltak et al., 
2009). To determine the genetic mechanisms underlying these variants, Poltak et al. 
(2009) fully sequenced three representative isolates (termed Studded [S], Ruffled 
Spreader [R] and Wrinkly [W]) from one laboratory-evolved population after 1500 
generations of adaptation to the biofilm-selective environment and identified putative 
adaptive mutations by comparison to the ancestral HI2424 genome. I would be able to 
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compare the mutations identified in my random screen to those identified in the 
biofilm-adapted isolates by Poltak et al. (2009) and look for overlapping mutations. 
As highlighted by Smith et al. (2006), adaptive mutations frequently arise in the 
CF lung in chronic Pseudomonas isolates in general, the most common being mutations 
in mex (multidrug efflux) genes and lasR (QS). Though they are not the most common 
isolates, SCVs or RSCVs are often recovered from CF patients just as they are 
experiencing a significant decline in lung function. The genetic basis of the SCV 
phenotype is not known for most isolates but it is clear that mutations leading to 
pooling of cyclic-di-GMP occur in all tested Pseudomonas RSCVs, which suggests that 
adaptation to a biofilm lifestyle in the lung predictably follows this path to produce this 
phenotype (Starkey et al., 2009). Biofilm-adapted populations of Burkholderia 
cenocepacia in our laboratory produced colony variants that resemble clinical RSCVs 
isolated from chronic CF lung infections and are highly adherent hyper-biofilm 
producers (Poltak et al., 2009). Since RSCVs in Pseudomonas are all linked by a common 
mechanism (pooling of cyclic-di-GMP), it is likely that the similar phenotypes from our 
laboratory have adapted using a similar genetic mechanism. Predictability of the 
outcome and genetic mechanisms of adaptation to a biofilm lifestyle is important 
knowledge for researchers exploring novel therapeutics to eradicate CF pathogens such 
as P. aeruginosa and B. cenocepacia by preventing the transition from an acute to a 
chronic infection. This leads to my third question: 
3. Do bacterial populations adapt to a biofilm lifestyle in a predictable manner? 
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To answer this question, I looked for mutations shared by laboratory-evolved 
isolates of B. cenocepacia across replicate populations. From the identified mutations in 
the three fully sequenced biofilm-adapted mutants, at least one mutation per mutant 
was predicted to result in cyclic-di-GMP pooling; these include mutations in the genes 
yciR, wspA and wspD. As mentioned previously, pooling of cyclic-di-GMP is a 
predictable adaptive trait found to occur in all of the studied P. aeruginosa RSCVs 
(Starkey et al., 2009). The finding that mutations occur that may be relevant to cyclic-di-
GMP pooling in the three representative evolved mutants prompted me to look at the 
many other collected mutants from replicate biofilm-evolved populations and start by 
searching for mutations in the yciR gene by targeted sequencing. 
Methods 
Strains and Culture Conditions 
E. coli DH5aXpir and GT115 and B. cenocepacia HI2424 and derivatives were 
routinely propagated at 37°C in T-Soy liquid (30g/LT-Soy powder) or on T-Soy solid agar 
(14g/L agar). 
Constructing a Tp-Resistant EZ-Tn5 Vector 
The EZ-Tn5 ™ pMOD ™ -5<R6Kyor/'/MCS>Transposon Construction Vector kit f rom 
Epicentre Biotechnologies was used to construct a tr imethoprim (Tp) resistant 
transposon for random mutagenesis of B. cenocepacia. The dihydrofolate reductase 
(dhfr) cassette conferring Tp resistance from plasmid pFTPl (Choi et al., 2005) was 
cloned into pMOD™-5<R6KYor/'/MCS>. Plasmids were digested with H/ndlll and the l k b 
dhfr fragment was isolated, gel-purified, and ligated into pMOD-5. Ligation products 
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were electroporated into E. coli DH5aXpir; recovered cells were plated on T-Soy agar 
(50jxg/ml Tp) and incubated overnight. Tp resistant colonies were screened by colony 
PCR using MasterTaq (Eppendorf) to verify presence of the dhfr cassette using the 
following cycling parameters and primers: 
ptnmoddhfr-F: 5'-TGGGTCAAAGTAGCGATGAAGCCA-3' 
ptnmoddhfr-R: 5'-ACGTTCAAGTGCAGCCACAGGATA-3' 
1 cycle 95°C 4min initial denaturation 
30 cycles 95°C 30sec denaturation 
60°C 30sec annealing 
72°C 30sec elongation 
1 cycle 72°C 7min final elongation 
PCR was routinely performed using the MasterTaq kit from Eppendorf according to 
manufacturer's directions, unless otherwise stated. The desired construct was verified 
by restriction digestion with PvuW and named pEZTnTp. 
Preparing the Transposome Mix 
The transposome mix for electroporation into target cells was prepared as per 
manufacturer's instructions (Epicentre). Instead of the PCR-based protocol I used the 
restriction digest method of liberating the Tn5Tp portion of the pEZTnTp plasmid. 
Concentrated plasmid DNA (~10jxg) was digested with PvuW and the 1.38kb TnTp 
fragment was isolated from the 1.6kb vector fragment by gel purification. DNA was 
eluted in TE buffer to avoid contaminating free magnesium to promote stability of the 
transposon:transposase complex (transposome) to be introduced into target cells. TnTp 
DNA was mixed with the kit transposase; the resulting transposome mix was incubated 
at 4°C overnight before storing at -20°C. 
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Preparing Electrocompetent Cells 
Bacterial cells were made electrocompetent by growing to mid-log phase 
(OD6OO=0.5) in liquid broth, harvesting by centrifugation at 4 ° C and rinsing with sterile 
deionized water twice, followed by one rinse in 10% (v/v) glycerol. Cells were finally 
pelleted, resuspended in 10% glycerol, aliquotted and stored at -80°C. 
Mutagenesis 
The TnTp transposome (lpil) was introduced into B. cenocepacia HI2424 by 
electroporation, spread plated on T-Soy (lOO^ig/ml Tp) and incubated 48hrs at 37°C. 
Resulting putative transposants were grown overnight in T-Soy (100|^g/ml Tp). Glycerol 
was added to a final concentration of 30% (v/v) and mixed before storing at -80°C. 
About 3,300 putative transposants were collected in this manner. 
Screening for Mutants with Increased Biofilm Production 
Biofilm production by all mutants was screened using a crystal violet microplate 
assay adapted from O'Toole et al. (1999). Initial biofilm assays were performed by 
replica-plating from freezer stock into T-Soy broth containing 150|a,g/ml tr imethoprim 
and growing overnight. Saturated cultures were sub-cultured into fresh broth by 
replica-plating and readings were recorded for optical density at 600nm ( O D 6 o o ) - After 
24hr incubation, final cell density ( O D 6 o o ) was recorded and liquid removed from wells 
by inversion. Remaining biofilm was heat-fixed at 80°C for 40min. and stained with 
0.01% (v/v) crystal violet for 20min. Stain was removed by inversion and samples were 
gently rinsed five times with deionized water. Samples were allowed to dry inverted for 
2min and were destained with a mixture of 80% (v/v) ethanol and 20% acetone for 
1 6 
15min. The O D 6 o o of the remaining crystal violet was recorded and directly 
corresponded to biofilm yield. 
Mutants with at least a 50% increase in total biofilm yield from the wild-type 
(WT) control of the same assay were selected. Biofilm assays were repeated on this 
subset of mutants in the same manner but with at least three replicate samples per 
mutant; 24 mutants were selected that met the 50% increase criterion. Significance of 
mutant biofilm increase compared to WT biofilm was evaluated by performing two-
tailed t-tests assuming equal variance. The 0.05 significance level was corrected by 
dividing by the number of independent tests (Bonferroni correction). 
Phenotype Screens of Biofilm Mutants 
The 24 mutants with increased biofilm production were tested for altered 
protease production, swarming motility, exopolysaccharide (EPS) production and colony 
morphology as these phenotypes are often co-regulated with biofilm production (Cunha 
et al., 2004; Huber at al., 2001). 
Protease production was evaluated by spot-plating 5|_il of saturated overnight 
culture on skim milk agar (T-Soy agar with 10% (v/v) skim milk) and incubating 
overnight. Zones of clearing on milk plates indicated protease production; the radius of 
the clearing was measured from the edge of the clearing to the edge of the spotted 
culture. Swarming motility was evaluated by point inoculating saturated overnight 
cultures onto low agar T-Soy (0.4% agar). Swarming distances were measured to the 
furthest point traveled from the point of surface inoculation. 
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EPS production was evaluated in a qualitative assay by spot plating overnight 
cultures onto Congo Red (CR) agar [1.5%T-Soy, 0.0015% CR, .004% Coomassie blue 
(adapted from Friedman and Kolter, 2004)], incubating overnight, and evaluating 
differential dye uptake. This medium allows better visualization of colony morphology 
as well as relative EPS production than routine culture on T-Soy agar. The redder the 
colony on CR agar, the less EPS was produced. Light red or colorless colonies on this 
medium would suggest greater EPS production. Each quantitative mutant phenotype 
was compared to that of the ancestor by two-tailed t-tests assuming equal variance. 
The 0.05 significance level was corrected by dividing by the number of independent 
tests (Bonferroni correction). 
Isolation of Genomic DNA and Verification of Source as Burkholderia 
Genomic DNA (gDNA) from putative mutants was prepared using a mini-prep 
salting-out method (Sambrook and Russell, 2001). Briefly, cells from overnight cultures 
were suspended in Tris-EDTA ( lOmM EDTA, lOmM Tris-CI pH8) and lysed overnight at 
37°C with shaking in buffer (1% SDS, 50mM Tris-CI pH8, 50mM EDTA pH8) containing 
100jAg/ml proteinase K. Saturated ammonium acetate was added and samples shaken 
vigorously and incubated l h r at room temp. Nucleic acids were extracted with 
chloroform to remove the proteins and lipids and then precipitated from the aqueous 
phase by adding 3 volumes of 100% ethanol and mixing by inversion. DNA was spooled 
and washed with 70% ethanol and dissolved in TE ( lOmM Tris, I m M EDTA, pH8) 
containing 50ng/ml RNase A. PCR targeting the 16S rDNA sequence was performed to 
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Cycling parameters were the same as for the PCR to amplify the dhfr gene except the 
annealing temperature was 55°C with lm in elongation. 
Rescue Cloning for Location of Insertion Mutations 
Genomic DNA (2pig) from putative mutants was digested with SsoHl, an enzyme 
that cuts about once every l kb within the HI2424 genome but not within the Tn5Tp 
sequence, and heat inactivated. Digested gDNA was self-ligated with T4 DNA ligase. 
Ligation products were transformed by electroporation into E. coli GT115 (Invivogen). 
Recovered cells were incubated overnight on T-Soy (50|^g/ml Tp). Plasmid DNA was 
harvested from Tp resistant colonies and was prepared for sequencing by mixing 5.5jxl 
of varying concentration (at least 28ng/^il) template DNA with 0.5^1 of IOjxM 
sequencing primer: EZ-Tn5™ pMOD™<MCS> Forward Sequencing Primer (5'-
GCCAACGACTACGCACTAGCCAAC-3') and sent to the Hubbard Genome Center for 
sequencing. 
Sequence Analysis 
Sequences were aligned to the B. cenocepacia HI2424 reference sequence 
(http://img.jgi.d0e.g0v/cgi-bin/w/main.cgi) using BLAST to identify locations of Tn5Tp 
insertions. The initial sequence generated from each sequencing reaction was that of 
transposon DNA since the primer anneals to the transposon facing out; the junction of 
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the transposon and the target gDNA was recognized by the 19-bp mosaic end sequence 
of the transposon (AGATGTGTATAAGAGACAG). The 'IMG Top Homologs' option was 
used to find annotations of domains of unknown function or hypothetical proteins. 
Whole-Genome Sequencing of Evolved Mutants 
Genomic DNA was isolated (as described above) from three representative 
isolates (wrinkly, ruffled spreader, studded) from one population following ~1500 
generations of experimental evolution favoring biofilm formation (Poltak et al., 2009). 
DNA was sent to the University of Houston for Solexa/lllumina sequencing; sequence 
was aligned to the reference B. cenocepacia HI2424 sequence and SNP's were identified 
using the programs ELAND (lllumina, San Diego) and MAQ 
(http://maq.sourceforge.net/). 
PCR Screen for Presence or Absence of yciR Homolog 
A PCR-based screen was performed to determine the presence or absence of the 
yciR homolog, Bcen2424_3554, in three evolved mutants from all six populations at 
1500 generations and biofilm population 1 at 450 generations. The template DNA was 
isolated as described above for most samples but a boiling lysis preparation was used 
instead for the 450-generation isolates because it required less time to perform. For 
those samples prepared by the lysate method, a small sample of a single colony was 
added to 20fxl of lysis buffer (0.25% SDS, 0.05N NaOH) and boiled at 95°C for 15min. 
Boiled samples were cooled and centrifuged and the supernatant was diluted 1:10 with 
sterile deionized water and centrifuged again before using as template DNA. PCR to 
amplify the 16S rDNA sequence was run to confirm that all template DNA comes from 
Burkholderia before performing PCR to amplify a portion of the yciR homolog. The 
primers used in the PCR screen for presence/absence of the yciR homolog were: 
yciR F: 5'-AGCAACATCACGGGCTTCTTC-3' 
yciR R: 5'-GCGACCTTCTGGTTCATCTC-3' 
Cycling parameters were the same as those used for PCR amplification of the dhfr gene 
except the annealing temperature was 57°C, with a 45sec. elongation and 5min. final 
elongation. 
Results 
Biofilm Gain-of-Function Mutant Phenotypes 
Out of 3,300 B. cenocepacia HI2424 TnTp insertion mutants, 24 exhibited 
increased (by at least 50%) biofilm production compared to wild-type HI2424 when 
evaluated in a crystal violet biofilm assay. These 24 mutants (numbered M1-M24, Table 
2.1) were also evaluated for a range of phenotypes often associated with altered biofilm 
production in other bacteria. The purpose of performing these additional phenotype 
screens was to further characterize the effects of the insertion mutations and the 
possible normal function of each disrupted gene or region of DNA in B. cenocepacia. 
Mutants were assigned a number preceded by 'M' (for mutant) from 1 to 24 based on 
the location in the genome or locus tag. 
The 24 mutants were screened for altered protease production, swarming 
motility, EPS phenotype and colony morphology (Table 2.1). In addition to Table 2.1, 
complete biofilm, protease production and swarming motility results are graphed for 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2 0 0 -
1 8 0 ~ 
160 
Figure 2.1: Increase In M u t a n t Scaled Biofilm Over W T Scaled Biofilm 
Original scaled biofi lm values were calculated by dividing the OD600 value of crystal violet by the 
OD600 value of the cell density after 24hr growth in a biofi lm assay to standardize biofi lm 
production per cell density. The percent increase of mutant biofi lm product ion was calculated 






Figure 2.2: Relative Protease Activity of Biofilm Mutants 
The relative protease activity of biofilm mutants was evaluated on skim milk agar plates. Radii 
of clearings (from the edge of growth to the outer edge of the clearing) were measured for each 
mutant wi th three replicates per plate. Error bars represent 95% confidence intervals. Mutant 
M13 was tested separately from the rest of the mutants and has its own WT reference for 
comparison, denoted by darker gray bars. Protease production of mutant M l was significantly 




Figure 2.3: Swarming Motility of Biofilm Mutants 
Overnight cultures were point inoculated in three replicates onto 0.4% agar T-Soy. Swarming 
motil ity was measured from the point of inoculation to the furthest distance traveled from that 
point. Error bars represent 95% confidence intervals. Only M6 was significantly different from 
WT for swarming motil i ty. 
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In B. cenocepacia, mutants defective in biofilm may also be defective in protease 
production and swarming motility if quorum sensing is altered (Huber et al., 2001; 
2002). Altered EPS production has been linked to changes in biofilm (Ferreira et al., 
2007) and colony morphology changes may correlate with altered biofilm production as 
well (Friedman and Kolter, 2004). 
Phenotypes of transposon mutants were compared to the wild-type B. 
cenocepacia HI2424 control and significance was evaluated as described in Methods 
(Supplementary Table 1). Mutant M l produced no protease (Figure 2.2) but 
significantly more biofilm than wild-type (WT) HI2424 (Supplementary Table 1). 
Mutants M7, M21 and M23 exhibited elevated protease production but were not 
significantly different from WT HI2424 (Figure 2.2; Supplementary Table 1). Mutant M6 
exhibited significantly higher swarming motility than WT, while M8 appeared to have a 
modest but not statistically significant swarming defect (Figure 2.3; Supplementary 
Table 1). Three mutants appeared to be significantly higher biofilm producers but did 
not exceed the Bonferroni-corrected p-values: M9, M22, and M23 (Figure 2.1; 
Supplementary Table 1). 
Interestingly, there was a range of colony characteristics, from WT (slightly 
mucoid) to 'matte' (not mucoid, not shiny). Only one mutant, M23, appeared to have a 
granular or studded colony surface on CR agar (Table 2.1). M24 did have a slightly 
granular or studded colony appearance but this was very subtle while M17 and M19 
each produced a more mucoid colony than WT. 
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Rescue-Cloned Transposon Mutants 
I determined the locations of each Tn insertion site by rescue cloning and 
sequencing (Table 2.1). Ten of the 24 insertion mutations mapped to the same region of 
chromosome 1 containing the web genes previously described (Cuccui et al., 2007) as 
capsular polysaccharide synthesis and export genes in B. pseudomallei (Figure 2.4). 
Cuccui et al. (2007) found that insertions in these homologs resulted in attenuated 
virulence in a mouse model of infection; a subset of the virulence mutants also had loss 
of capsule polysaccharide. However, these genes have not been previously 
characterized as having a role in biofilm formation in B. cenocepacia or other members 
of the Bcc. Four of the insertions from my study are in a large 7.6kb gene annotated as 
wcbR in B. pseudomallei, a capsule polysaccharide biosynthesis gene coding for a 
polyketide synthase, which did not result in virulence attenuation when mutated by 
Cuccui et al. (2007). 
The eight protein domains in wcbR in HI2424 are shown in Figure 2.5. Each 
insertion mutation in this gene mapped to a different functional region. Mutant M8 had 
the transposon insertion between the acyltransferase and the methyltransferase 
domains, while the insertion in M9 is mutated between the last two domains, 
polyketide synthase and PPP binding. Mutant M10 received the Tn5Tp insertion 5' to 
the beta-ketoacylsynthase C terminal domain and the insertion was found within the 
alcohol dehydrogenase zinc-binding domain in M i l . Each of the protein domains of 
wcbR has a putative role in fatty acid chain synthesis for capsule formation; interrupting 











Figure 2.4: Chromosome View of web Region 
Shown here is the JGI chromosome view of the region where ten insertion events occurred. The 
majority of these are in the web genes annotated as encoding capsular polysaccharide synthesis 
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Figure 2.5: Protein Domains of WcbR 
The beta-ketoacylsynthase, wcbR, is comprised of eight main protein domains. The active site of 
this protein is located between the N and C beta-ketoacylsynthase terminal domains. In order, 
the domains are: beta-ketoacylsynthase (N-terminal), beta-ketoacylsynthase (C-terminal), 
acyltransferase, methyltransferase type 12, alcohol dehydrogenase (GroES-like), alcohol 
dehydrogenase (zinc-binding), polyketidesynthase (KR), phosphopantetheine-binding. Triangles 
indicate TnTp insertion locations within wcbR. Domains are not to scale. 
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capsule production. Fatty acid-based lipids are important structural components of 
many bacterial capsules, such as variations produced by E. coli and Neisseria 
meningitidis (reviewed by Whitfield, 2006). The precise structure of the B. cenocepacia 
HI2424 capsule is unknown. 
Sequencing of Experimentally-Evolved Mutants Adapted to Biofilm Growth 
Our lab (Poltak et alv 2009) sequenced three laboratory-evolved mutants of B. 
cenocepacia HI2424 which displayed 1-fold to 4-fold increases in biofilm production to 
identify the genetic bases of biofilm adaptation. These mutants (S, R and W) were 
isolated from one population and each contained mutations related to cyclic-di-GMP 
turnover, as well as several other mutations in pathways such as iron sequestration, 
general efflux, 
polysaccharide synthesis and general metabolism. Here I will discuss mainly those 
mutations with potential for affecting cyclic-di-GMP turnover (Table 2.2): the yciR 
homolog deletion occurring in all three morphotypes (S, R and W), the wspA mutation in 
W, and the wspD mutation in R. 
Adaptive Loss of yciR in Evolved Mutants 
A PCR screen of S, R, and W isolates from six replicate biofilm-evolved 
populations revealed that most, 16 of 21 isolates, lost the yciR gene, though biofilm 
population 1 from 450 generations produced a W isolate that still has the yciR gene 
(Table 2.3). All R isolates lost yciR but two S isolates and two W isolates from 
populations from 1500 generations retained the gene. Only one of the replicate 
planktonic populations lost its yciR gene (Table 2.3). 
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Table 2.2: Mutat ions in Fully Sequenced Biofilm-Evolved Isolates f rom 1500 
Generations 
Columns are the fully sequenced morphological variants of one population of B. cenocepacia 
adapted to the biofilm environment over 1500 generations of evolution and rows are the 
mutation(s) thought to be associated with cyclic-di-GMP turnover and leading to increased 
biofilm in each isolate. An 'X' indicates that the mutation occurs in the isolate at the top of the 
column. 
Studded Ruffled Spreader Wrinkly 
95 gene deletion: yciR X X X 
SNP in wspA homolog X 
SNP in wspD homolog X 
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Table 2.3: yciR Screen of Planktonic and Biofilm Isolates 
The presence or absence of yciR was determined by PCR in isolates from all adapted populations 
after 1500 generations and one population after 450 generations of biofilm evolution, including 
the six planktonically evolved populations. A 'yciR-' indicates that the yciR gene was no longer 
present in the isolate. A '+' symbol indicates that a portion of the yciR gene was successfully 
amplified from the specified isolate. Gray boxes indicate that the respective morphology was 
not present in the population. The three isolates from biofilm population 1 were fully 
sequenced after 1500 generations of evolution. 
Ancestra I 
Popu la t ion* . . . S tudded Ruff led Spreader Wr ink ly 
Morpho logy 
Biof i lm 1 
(450generat ions) yciR- yciR- + 
Biof i lm 1 
yciR- yciR- yciR-(1500generat ions) 
Biof i lm 2 + yciR- yciR-
Biof i lm 3 + yciR- yciR-
Biof i lm 4 yciR- yciR- yciR-
Biof i lm 5 yciR- yciR- + 




Planktonic 3 + 
Planktonic 4 + 
Planktonic 5 + 
Planktonic 6 + 
*1500generations unless otherwise noted 
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Discussion 
Mutations Increasing Biofilm Production in B. cenocepacia 
I sought to identify mutations that positively influence biofilm production in B. 
cenocepacia and found mutations in 21 unique genes in 24 mutants from a transposon 
library of 3,300. This approach has not been previously used in B. cenocepacia; biofilm 
genes have traditionally been identified by random screening for biofilm defects. 
Although more mutants could have been collected to identify other biofilm regulatory 
genes, 24 mutants were sufficient to identify genes previously uncharacterized as having 
a role in biofilm formation in B. cenocepacia. 
One-third of these genes (7) are in homologs of the web operon previously 
characterized in B. pseudomailei (Cuccui et al., 2007), where it controls capsular 
polysaccharide biosynthesis. Absence of capsule production in B. pseudomailei results 
in attenuated virulence in mouse models of intraperitoneal and intranasal infection 
(Cuccui et al., 2007). The study by Cuccui et al. did not test these mutants for biofilm 
production, but absence of capsule production has been shown to increase biofilm 
production in the pathogens Vibrio vulnificus (Joseph and Wright, 2004), Porphyromonas 
gingivalis (Davey and Duncan, 2006), and Neisseria meningitidis (O'Dwyer et al., 2009). 
It is noteworthy that a loss of capsule in N. meningitidis also correlated with colony 
variation; rough, acapsular small colony variants frequently are produced in N. 
meningitidis biofilms (McEllistrem et al., 2009). N. meningitidis is a member of the (3-
proteobacteria, as is B. cenocepacia, and is therefore a close relative whose capsule 
functions and biofilm regulation may be similar. 
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It is interesting that 10 of the 24 gain-of-function biofilm mutants (~42%) from 
my screen have insertions in the same region of chromosome 1, the web operon. This 
region was also found to be a Tn5 insertional hotspot in B. pseudomailei (Cuccui et al., 
2007). Cuccui et al. selected 39 virulence-attenuated signature-tagged mutagenesis 
mutants from 892 mutants screened. Of those, 22 insertions (~57%) were in the web 
operon. The investigators proposed that this region was more prone to insertion by Tn5 
since it had a 10% lower G+C content (58% G+C) than the rest of the genome (67% G+C). 
Upon investigating the homologous region in B. cenocepacia HI2424 containing the web 
operon, I have found that the region in also has a lower GC content (50-58% G+C) than 
the rest of the genome (67% G+C) except for the wcbR homolog, which is higher (71% 
G+C) in G+C content than the genome average. My random approach may have been 
biased toward tranposon insertion in the web operon for the same reason proposed by 
Cuccui et al. (2007), but the four insertions in wcbR do not support this argument since 
its G+C content is actually greater than the genome average. The chances of four 
insertion events occurring in the same gene from only 3,300 mutants are low, especially 
given that the genome of B. cenocepacia HI2424 contains 7,050 genes. However, wcbR 
is a large target of 7.6 kb, representing 0.1% of the total genome, so finding at least one 
mutant is not improbable. 
Other genes harboring transposon mutations that increased biofilm production 
in my study include gspN, phoH, algP, marR, traB and oprB. The gspN gene encodes a 
protein in the general secretory pathway II, which was previously identified as having a 
role in biofilm production by B. cenocepacia in a screen of mutants defective in biofilm 
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production (Huber et al., 2002). The gspE insertion mutant characterized in that study 
caused a biofilm defect, whereas the gspN insertion in my study increased biofilm 
production. 
The PhoH protein is annotated as a phosphate starvation-inducible protein and 
as a predicted ATPase. PhoH was first characterized in E. coli by Kim et al. (1993) and 
has a putative role in the transport and use of various forms of combined or free 
phosphate. The algP gene has been identified in P. aeruginosa as an important 
regulatory gene in alginate production (EPS), a key pathogenic factor important in 
chronic CF lung infections (Konyecsni and Deretic, 1990). B. cenocepacia is not known 
to produce alginate, and thus this pathway likely has another function in this organism. 
The MarR family of proteins is annotated as transcriptional regulators, which 
could possibly control the transcription of any number of factors important to biofilm 
formation. A mutation in a gene encoding a protein belonging to the MarR family was 
identified in 5. aureus that resulted in increased biofilm formation (Tamber and Cheung, 
2009). The TraB protein is annotated as having a role in pilus assembly but traB has no 
previously known connection to biofilm formation. OprB is annotated as a 
carbohydrate-selective porin and has been characterized in B. pseudomallei as a 
component of an efflux pump that is necessary for optimal biofilm production and 
virulence (Chan and Chua, 2005). It is noteworthy that the insertion in oprB f rom the B. 
pseudomallei mutant screen has the opposite effect on biofilm production of the oprB 
mutant in my study. Insertions in different locations within the same gene may result in 
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either knockout or overexpression of the gene, depending on the promoter associated 
with the transposon and whether or not it also contains a stop codon. 
Though I expected that mutations resulting in increased intracellular pooling of 
cyclic-di-GMP would be identified in this screen, I do not have enough information to 
rule out a role for any of the 24 mutations in cyclic-di-GMP turnover. None of the 
transposon insertions mapped to genes coding for predicted phosphodiesterases or 
diguanylate cyclases that may be involved in cyclic-di-GMP turnover. However, that 
does not mean that the genes identified cannot have a regulatory role or be regulated 
themselves by cyclic-di-GMP such as the tbpA mutation in P. aeruginosa (Ueda and 
Wood, 2009) that leads to increased levels of cyclic-di-GMP through overexpression of a 
diguanylate cyclase. It may be necessary to perform measurements of intracellular 
levels of cyclic-di-GMP to answer the question of whether or not this mechanism 
increases biofilm production in any of these mutants. 
Genes Identified by Random Mutagenesis not Implicated in Adaptation to Biofilm 
Lifestyle 
Of the 21 genes that I have identified as regulating biofilm formation in 6. 
cenocepacia, none acquired mutations in the three mutants that rose to high frequency 
during prolonged biofilm selection (Poltak et al., 2009). However, defective capsule 
production may be a common mechanism for increased biofilm formation between the 
two groups. Indeed, loss of capsule is known to positively affect biofilm formation in N. 
meningitidis and some rough small colony variants of this organism are defective in 
capsule production (McEllistrem et al., 2009). In the future we plan to characterize the 
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capsule production of both the transposon mutants and the evolved biofilm system 
mutants by either simple staining or immunostaining and confocal microscopy. 
Predictability of Adaptation to a Biofilm Lifestyle 
In each biofilm-adapted population produced by Poltak et al. (2009), a mutant 
featuring a deletion of the yciR gene was found, supporting the hypothesis that 
populations of 6. cenocepacia predictably adapt to a biofilm lifestyle. Fixation of this 
mutation within these biofilm-adapted populations may be due to a selective advantage 
conferred in the biofilm environment by increased intracellular pooling of cyclic-di-GMP, 
since this gene may function as a phosphodiesterase that would normally break down 
the bacterial second messenger. 
The importance of studying a CF pathogen such as B. cenocepacia and identifying 
and characterizing genes involved in biofilm regulation is that we know that adaptation 
occurs in the CF lung (Haussler, 2004; Haussler et al., 2003, Starkey et al., 2009) but we 
do not know the genetic mechanisms of this adaptation. I am particularly interested in 
how biofilm-adapted populations of B. cenocepacia produce small colony variants (SCVs) 
that are highly adherent and exhibit increased biofilm production as well as altered 
colony morphology because clinical SCVs of B. cenocepacia and P. aeruginosa in the CF 
lung lead to a poor prognosis for patients and correlate with post-transplant fatalities in 
the CF population (Haussler et al., 2003). It is critical for development of future 
treatment of clinical SCVs that we know the genetic basis of the biofilm-adapted SCV in 
B. cenocepacia and whether this phenotype that occurs reproducibly in a laboratory 
biofilm evolution arises from a predictable genetic mechanism. 
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Supplementary Table 1: Phenotypic Changes in Biofilm Mutants Over WT 
The observed phenotypes for protease and swarming are shown along wi th the t-test statistic 
for each mutant compared to WT, including the results for t-tests of scaled biofilm values. The 
Bonferroni corrected significance level (0.05/24) is 0.002; any statistic above this value is not 
considered significant. Gray highlighted values indicate a significant difference from WT. 
Mutants M9, M22 and M23 were not significantly different from WT in biofilm production. 
Mutant Protease T-test Statistic Swarming T-test Statistic T-test Statistic for Biofilm Increase 
M l negative 0.000 0.398 0.001 
M2 0.184 0.700 0.000 
M3 0.624 0.381 0.001 
M4 0.180 0.732 0.000 
M5 0.094 0.098 0.000 
M6 0.252 higher 0.002 0.000 
M7 high 0.012 0.163 0.000 
M8 0.050 lower 0.018 0.002 
M9 0.879 0.037 0 .004 
M10 0.033 0.357 0.000 
M i l 0.463 0.404 0.000 
M12 0.329 0.897 0.000 
M13 0.349 0.897 0.000 
M14 0.033 0.934 0.000 
M15 1.000 0.126 0.000 
M16 0.050 0.094 0.000 
M17 0.124 0.204 0.002 
M18 0.242 0.807 0.000 
M19 1.000 0.102 0.000 
M20 0.463 0.611 0.000 
M21 higher 0.016 0.386 0.000 
M22 0.185 0.126 0 .011 
M23 higher 0.022 0.219 0 .029 
M24 0.067 0.381 0.000 
37 
CHAPTER 3 
GENETIC MECHANISMS OF INCREASED BIOFILM PRODUCTION in B. CENOCEPACIA 
Introduction 
Populations of B. cenocepacia evolved in the laboratory under conditions 
favoring biofilms produce significantly more biofilm than the ancestral isolate (Poltak et 
al., 2009). We hypothesize that these evolved populations adapted to growth in 
biofilms by similar mechanisms to mutants recovered from the lungs of CF patients in 
chronic stages of infection. Our preliminary data on the physiology and genetics of the 
evolved populations support this hypothesis, but the precise genetic mechanisms 
remain to be confirmed. We suggest that these laboratory-evolved populations could 
potentially be used to model bacterial evolution during chronic infections. 
I have attempted to determine some of the key molecular mechanisms by which 
B. cenocepacia has adapted to life in a biofilm in a laboratory system. Whole genome 
sequencing of three mutants from one population that evolved for 1500 generations 
shows that at least 12 mutations have occurred. Seven of these mutations were 
nonsynonymous substitutions, three were in promoter regions and two involved large, 
multiple gene deletions (Poltak et al., 2009). I focused on one of these genes, yciR, to 
characterize its function and relevance to the adaptation to a biofilm lifestyle. The 
predicted YciR protein (Figure 3.1) has both EAL and GGDEF domains that are found in 
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phosphodiesterase and diguanylate cyclase enzymes, respectively, that break down or 
synthesize cyclic-di-GMP (Hengge, 2009). Low levels of cyclic-di-GMP are known to 
promote a motile lifestyle and high levels elicit the opposite response, promoting 
biofilm production in P. aeruginosa and other bacteria (Hengge, 2009). 
PAS GGDEF H EAL 
Figure 3.1: Protein Domains of YciR 
The PAS domain may function as a signal receiver, while the GGDEF domain is a predictor of 
diguanylate cyclase function. The EAL domain likely functions as a phosphodiesterase that 
breaks down cyclic-di-GMP. 
Intracellular pooling of cyclic-di-GMP is responsible for colony morphology 
changes from smooth to wrinkled colonies as well as increased biofilm formation and 
decreased motility in P. aeruginosa, Vibrio, and more (Kulasekara et al., 2005, Lim et al., 
2007, Ryan et al., 2006b, Tischler and Camilli, 2005). These phenotypes associated with 
cyclic-di-GMP are exhibited by each of three distinct variants that arose during 1500 
generations of laboratory selection for biofilm formation (Poltak et al., 2009). These 
phenotypes, taken together with our sequencing data that show mutations in genes 
predicted to be relevant to cyclic-di-GMP turnover (yciR, wspA and wspD), suggest that 
pooling of cyclic-di-GMP is occurring in the three mutants of interest, S, R and W. 
In order to show that the yciR deletion produced the observed phenotypes 
(wrinkly colonies, increased biofilm and decreased motility), I provided biofilm-adapted 
mutants with a functional copy of the mutated gene in trans based on the prediction 
that genetic complementation would reverse some or all of the observed phenotypes to 
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wild-type HI2424. The yciR deletion occurs in all three sequenced W, R and S isolates, 
whereas the wspA and wspD SNPs occur in only W and R, respectively. 
I genetically complemented yciR in R, S and W isolates from two time points in 
the laboratory evolution, 450 and 1500 generations, and screened for changes in biofilm 
production, colony morphology and motility, as well as changes in colonization 
efficiency (fitness) in the biofilm environment to which the mutants had been adapted. 
I initially complemented yciR in S, R and W from 1500 generations of biofilm evolution 
and subsequently complemented the S, R and W isolates from 450 generations of 
biofilm evolution, even though the genomes of these earlier isolates have not yet been 
fully sequenced. It is likely that fewer mutations had accumulated by 450 generations 
than at 1500 generations. Therefore, I expected better (closer to wild-type) 
complementation of colony morphology, biofilm production, motility and fitness in the 
biofilm environment by the introduction of intact yciR in trans into the 450 generation 
isolates than the 1500 generation isolates due to epistatic effects of additional 
mutations after 1500 generations. 
Methods 
Strains and Culture Conditions 
E. coli GT115 (Invivogen) and TOPIO (Invitrogen) and B. cenocepacia HI2424 and 
derivatives were routinely propagated at 37°C in T-Soy liquid (30g/L T-Soy powder) or 
on T-Soy solid agar (14g/L agar). 
Cloning yciR for Genetic Complementation 
After a series of cloning steps, an intact copy of yciR was cloned into a stably 
maintained vector, pBBRlMCS (Kovach et al., 1994), for genetic complementation, as 
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described below. The wild-type yciR gene from B. cenocepacia HI2424 was amplified by 
PCR with MasterTaq (Eppendorf) using the following primers and cycling parameters: 
yciR comp F: 5'-TCACGGCAATCACGGCAG-3' 
yciR comp R: 5'-ATCTACACGGGCTTCGGCAC-3' 
1 cycle 95°C 4min initial denaturation 
25 cycles 95°C 30sec denaturation 
58.6°C 30sec annealing 
72°C 2min 30sec elongation 
1 cycle 72°C 5min final elongation 
PCR was routinely performed using the MasterTaq kit from Eppendorf according to 
manufacturer's directions, unless otherwise stated 
PCR products were cloned into pCR®-XL-TOPO (Invitrogen). Cloning products 
were transformed by electroporation into One Shot® TOPIO Electrocompetent E. coli 
(Invitrogen) at 1.8Kv in a 1mm gap cuvette. Cells were recovered and spread-plated 
.onto T-Soy agar containing 50ng/ml kanamycin (Kan). Plasmid DNA was isolated from 
Kan-resistant colonies using the Wizard® Plus SV Minipeps DNA Purification System. 
Plasmid DNA was screened for presence of yciR by PCR using the yciRcomp primers as 
described in Chapter 2 and one correct clone was named pyciRTOPO. 
The yciR gene was excised from pyciRTOPO by double digestion with Xba\ and 
H/ndlll (NEB) and gel purified using the Wizard® SV Gel and PCR Clean-up System. The 
broad-host range vector pBBRlMCS was also double digested with Xba\ and H/'ndlll. The 
digested and gel purified yciR gene and double digested pBBRlMCS were ligated at a 6:1 
(suggested by manufacturer) insert:vector ratio with T4 DNA ligase (NEB) at 16°C 
overnight. 
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Ligation products were transformed by electroporation into E. coli GT115 
(Invivogen) as described in Chapter 2. Plasmid DNA was isolated as described above and 
screened for presence of yciR by PCR; one correct clone was named pyciRcom. The 
complementation vector, pyciRcom, was electroporated into electrocompetent evolved 
isolates of Burkholderia, prepared and electroporated as described in Chapter 2. The 
pBBRlMCS vector served as a positive control and a cell only 'no DNA' control was also 
included as a negative control. Recovered cells were plated on T-Soy agar containing 
lOOjxg/ml chloramphenicol (Cm) and incubated overnight. Cm-resistant colonies were 
screened by colony PCR using the yciRcom primers. 
Phenotype Screens for Effects of Genetic Complementation 
Biofilm, swarming motility, colony morphology and protease production were 
evaluated to determine the effects of genetic complementation with yciR on biofilm 
adapted isolates of B. cenocepacia HI2424. Biofilm assays were performed as described 
in Chapter 2 except that 24-well plates were used for the 450 generation samples in 
addition to the 96-well plate assay since error was high for these samples in the smaller 
volume wells perhaps due to biofilm clumps detaching from the inside well surface. 
Swarming motility of 450 generation samples was evaluated by point-inoculating 
saturated overnight cultures onto 0.4% agar T-soy and measuring distance traveled from 
inoculation point after 24 hours. Protease production of 450 generation isolates was 
evaluated by spotting 5jxl of saturated overnight culture onto 2% skim milk T-Soy agar 
plates and incubating overnight. Zones of clearing indicating protease production were 
measured as the distance from the edge of the colony to the outer edge of the clearing. 
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Colony morphology of all isolates was evaluated by isolating colonies on Congo Red (CR) 
agar [1.5%T-Soy, 0.0015% CR, .004% Coomassie blue (adapted from Friedman and 
Kolter 2004)]. 
Assays of Mutant Fitness 
The fitness of evolved mutants and mutants complemented with pyciRcom was 
measured in the laboratory biofilm evolution environment. Cultures were started from 
single colonies on T-Soy with or without 100^g/ml Cm and grown for 24hrs in evolution 
medium (3% galactose M9 minimal medium) with a 3mm polystyrene bead. Beads were 
removed with bent inoculating loops and vortexed in 1.5ml of PBS (0.765% NaCI, 
0.0724% Na2HP04, 0.021% KH2P04) twice for lOsec. Replicate samples were taken from 
the vortexed bead broth and diluted 1:50 in fresh evolution medium with a fresh bead. 
Samples from each replicate were diluted and plated onto 1.5% T-Soy agar and 
incubated overnight to estimate culture density at t=0 and observe colony morphology. 
The 1:50 dilutions in fresh medium with a fresh bead were incubated for 24 hrs; cells 
were harvested from beads in the same manner as the initial t=0 cultures. Harvested 
cells were diluted and plated onto 1.5% T-Soy agar and incubated overnight for t=24hrs 
cell density calculations. Biofilm fitness was calculated as the logarithm of the increase 
in cells attached to the bead over 24h, as follows: ln[(CFU/ml24hrs)/(CFU/ml0hrs)]-
Assay of Relative Quorum-Sensing Molecule Production 
A GFP-based reporter assay was performed on evolved isolates to determine 
changes in production of C8-homoserine lactones (C8 HSL) as described (Steidle et al., 
2001). Evolution medium cultures (with and without bead) were started from single 
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colonies and grown overnight. Cultures were centrifuged and supernatants were filter-
sterilized (0.22nm cellulose acetate column filter, Corning). Cell-free supernatants were 
diluted 1:11 in sterile deionized water and dilutions mixed 1:1 with log phase sensor 
strain, Pseudomonas putida F117 pAS-C8, that had been grown overnight at 28°C in 
liquid T-Soy containing 20(xg/ml gentamycin and sub-cultured on day of assay. Sensor 
strain and cell-free supernatants were incubated overnight at 28°C with shaking. 
Fluorescence intensity readings were taken on the plate reader (Tecan) in a 96-well 
black plate with clear well bottoms using the settings for optimal gain with excitation at 
474nm and emission at 515nm. Negative controls included E. coli OP50 as well as the 
HI2424-R cepR knockout strain that is defective in QS molecule production (Chapter 3); 
the blank was a 1:1 mix of sensor strain and liquid T-Soy. 
Scanning Electron Microscopy (SEM) 
Cultures for SEM were grown in evolution medium with bead (started from 
single colonies) overnight (~23hrs) at 37°C. Beads were removed with a bent 
inoculating loop and suspended in 3% gluteraldehyde at 4°C for 3hrs. Beads were 
washed twice in PBS before a series of ethanol washes, each for lOmin: 30%, 50%, 70%, 
95%, and two 100% washes. Two final hexamethyldisilazane (HMDS) washes were 
performed before allowing beads to air dry. Dry beads were mounted on adhesive tape 
for transport before further drying and coating with gold and palladium. SEM images 




Genetic Complementation of yciR 
Evolved isolates of B. cenocepacia HI2424 from 450 and 1500 generations of 
biofilm adaptation containing no introduced vector, containing the control vector 
pBBRlMCS, or containing the complementation vector, pyciRcom, were tested for 
phenotypic changes in a variety of settings. Phenotypes of complemented isolates were 
compared to phenotypes of isolates harboring the empty control vector, pBBRlMCS 
(Table 3.1). None of the evolved isolates were fully restored to wild-type phenotypes 
when complemented with the yciR gene. Wild-type B. cenocepacia HI2424 did not show 
any phenotypic changes when provided an extra copy of yciR in trans except that 
increased protease production was observed (Table 3.1; Figure 3.2). 
Fewer phenotypic changes were observed in the yciR complemented isolates at 
1500 generations than the yciR complemented 450 generation isolates (Table 3.1). The 
isolates from 1500 generations did not undergo changes in their colony morphologies 
when complemented with yciR (data no shown), but did show some changes in biofilm 
production, fitness, and yield when possessing the complementation vector pyciRcom. 
Complemented Wi50o(W isolate from 1500 generations) exhibited significantly reduced 
biofilm and increased fitness (Figure 3.3). R1500 also had significantly reduced biofilm, 
but no other phenotype tested was changed. S1500 did not undergo changes in biofilm 
or fitness, but was the only 1500 generation isolate to exhibit a significant reduction in 
C8-HSL production (Figure 3.4). I chose to include relative C8-HSL QS molecule 
production in this analysis because a yciR mutant in B. cenocepacia H i l l was previously 
shown to be defective in QS molecule production (Huber et al., 2002) and I predicted 
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Table 3.1: Summary of yciR Complemented Phenotypes for Isolates Containing 
pyciRcom Relative to Empty Vector Control 
The complemented phenotype data for each biofilm-adapted isolate is compared to empty 
vector data for isolates. 'Unchanged' denotes no significant difference from empty vector; 
'Increased' or 'Reduced' denotes a significant phenotype change relative to the empty vector 
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fcJ Protease Swarm Motility 
Figure 3.2: Swarming Motility and Protease Production of yc/ff-Complemented 450 
Generation Isolates 
For each isolate tested for biofilm production there is the test strain containing pyciRcom, a 
control strain containing pBBRlMCS, and the original strain. 'WT' represents 8. cenocepacia 
HI2424; 'S' 'R' and 'W' represent the studded, ruffled spreader and wrinkly morphotypes, 
respectively. Zones of clearing on milk agar were measured for relative protease production for 
each sample and swarming motil ity was measured on 0.4% agar T-Soy as the farthest distance 
traveled from point of inoculation. Error bars represent 95% confidence intervals, n=3. 
Significant differences between transformation with pyciRcom and pBBRlMCS are seen for WT, 
W450 and R450 for protease production. There is a significant difference between the two 
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Figure 3.3: Bead Yield. Fitness and Scaled Biofilm of vciR-Complemented Isolates at 
1500 generations 
For each isolate there is an isolate containing pyciRcom, a control containing pBBRlMCS, and 
the original strain. 'WT' refers to B. cenocepacia HI2424; 'S' 'R' and 'W' represent the studded, 
ruffled spreader and wrinkly morphotypes, respectively. Bead yield (A), fitness (B) and scaled 
biofilm (C), were calculated. Scaled biofilm values were calculated by dividing the OD60o values 
of crystal violet per sample by the OD600 of the 24hr cell growth. Error bars represent 95% 
confidence intervals, n=3 for bead assays; n=7 for biofilm assay. Light gray bars indicate a 
significant difference between the phenotype indicated for that isolate wi th pyciRcom versus 




Figure 3.4: Relative C8-HSL Production of vc/'ff-Complemented 450 Generation Isolates 
For each isolate tested for biofilm production there is the test strain containing pyciRcom, a 
control strain containing pBBRlMCS, and the original strain. 'WT' represents B. cenocepacia 
HI2424; 'S' 'R' and 'W' represent the studded, ruffled spreader and wrinkly morphotypes, 
respectively. Fluorescence intensity was measured for each supernatant sample mixed wi th 
sensor strain. Relative C8-HSL production is calculated by dividing the fluorescence intensity by 
log transformed OD6oo of test sample pre-filter. Error bars represent 95% confidence intervals, 
n=3 from one assay. Light gray bars indicate a significant difference between the relative QS 
molecule production indicated for that isolate wi th pyciRcom versus the empty vector control, 
pBBRlMCS. 
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that providing yciR in trans would increase QS production in the defective biofilm 
isolates. 
All three morphological variants (S, R and W) from 450 generations exhibited 
phenotype changes when complemented with the yciR complementation vector, 
pyciRcom. W45o showed the most changes after complementation, though this is the 
only isolate that still contains the yciR gene (Table 2.3) as verified by a PCR screen. 
Reductions were observed in biofilm (Figure 3.5), bead fitness (Figure 3.6A), and C8-HSL 
production (Figure 3.4), and an increase was seen in and swarming motility (Figure 3.2). 
Colony morphology of W450 reverted back to the WT slightly mucoid appearance but 
remained small in size (Figure 3.7). 
Scanning electron microscopy revealed that biofilm formation on a bead is altered in the 
complemented W450, which covers the bead more evenly than the clumping seen in the 
controls (Figure 3.8). Cell size of W450 changed when complemented; cells appeared 
longer and more like WT (Supplementary Figure 1). 
The R 4 5 0 isolate had reduced biofilm (Figure 3.5) and bead yield (Figure 3.6B) 
with an in trans copy of yciR, though bead fitness was unchanged. Relative quorum 
sensing molecule production was increased (Figure 3.4), as was protease production 
(Figure 3.2), though swarming motility remained the same. Colony morphology did not 
revert to WT, but did change from tight wrinkles to a more spreading, less wrinkly 
colony (Figure 3.7). Coverage on the bead also changed from many biofilm clumps to 
fewer clumps (Figure 3.8). 
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Figure 3.5: Biofilm Production of yciR Complemented 450 Generation Isolates 
For each isolate tested for biofilm production there is the test strain containing pyciRcom, a 
control strain containing pBBRlMCS, and the original strain. 'WT' represents B. cenocepacia 
HI2424; 'S' 'R' and 'W' represent the studded, ruffled spreader and wrinkly morphotypes, 
respectively. Scaled biofilm values were calculated by dividing the OD600 values of crystal violet 
per sample by the OD600 of the 24hr cell growth prior to performing the staining portion of the 
biofilm assay. Error bars represent 95% confidence intervals, n=4. Light gray bars indicate a 
significant difference between the scaled biofilm for that isolate wi th pyciRcom versus the 
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Figure 3.6: Fitness and Bead Yield of Complemented 450 Generation Isolates 
For each isolate tested for absolute fitness on a bead (A) and bead yield (B) there is the test 
strain containing pyciRcom, a control strain containing pBBRlMCS, and the original strain. 'WT' 
represents B. cenocepacia HI2424; 'S' 'R' and 'W' represent the studded, ruffled spreader and 
wrinkly morphotypes, respectively. The suffix 'yciR' implies introduction of pyciRcom and 
'pBBRlMCS' the control vector pBBRlMCS. Error bars represent 95% confidence intervals n=3 
except for S450, n=2. Light gray bars indicate a significant difference between the bead yield 
indicated for that isolate with pyciRcom versus the empty vector control, pBBRlMCS. 
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no vector control pyciRcom 
Figure 3.7: Colony Morphologies of 450 Generation Isolates 
Digital photographs of each isolate were taken after allowing colonies to develop at room 
temperature for a week after initial overnight incubation at 37°C on CR agar. 'WT/ 'W450/ 
'R450,' and 'S450' refer to B. cenocepacia HI2424, and three 450 generation isolates wrinkly, 
ruffled spreader and studded, respectively. All pictures are representative of the colonies f rom 
each sample and are shown at the same scale. Column labels of 'no vector,' 'pBBRlMCS 
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Figure 3.8: Scanning Electron Micrographs of vc/fl-Complemented 450 Generation Samples on Beads 
Composite pictures were assembled at 1,000X magnifications of the three evolved morphotypes at 450 generations. 
The S450 isolate had reduced biofilm (Figure 3.5), but unchanged bead fitness and 
yield (Figure 3.6). C8-HSL production increased (Figure 3.4), protease was unchanged 
and swarming motility was reduced (Figure 3.2). Colony morphology changed from 
many small wrinkles to a flatter, crater-studded colony with some wrinkles (Figure 3.7) 
but any change in bead coverage change was subtle, with the complemented S450 
appearing to have more sparse coverage (Figure 3.8). 
Discussion 
The goal of this study was to genetically complement one mutation, the yciR 
deletion, acquired after laboratory biofilm adaptation in three fully sequenced isolates 
from 1500 generations of adaptation from one population. The yciR gene is attractive 
to study because it contains an EAL amino acid motif that often identifies a 
phosphodiesterase that breaks down cyclic-di-GMP (Hengge, 2009). This deletion may 
lead to increased levels of intracellular cyclic-di-GMP, which has been shown to lead to 
increased biofilm production and wrinkly or rugose colony morphology (Hengge, 2009), 
similar to the phenotypes observed in the three genotype variants sequenced from 
1500 generations. 
It is noteworthy that the yciR deletion is the starting point of a large 95-gene 
deletion that occurred in all three sequenced evolved isolates of B. cenocepacia HI2424 
(Poltak et al., 2009). The deletion of yciR in all three morphotypes of B. cenocepacia (S, 
R and W) at 1500 generations of evolution from an adaptive biofilm population, as well 
as the SNPs in the wspA gene in the W isolate and wspD in the R isolate (Poltak et al. 
2009), suggests that selection to form more biofilm favored increased intracellular 
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concentrations of cyclic-di-GMP. These three mutations all have implications for 
increased intracellular pooling of cyclic-di-GMP. First, we know that a yciR deletion in E. 
coli (Weber et al., 2006) and Salmonella (Garcia et al., 2004) increased biofilm 
production and I predicted that the complete deletion of the gene, as occurred in the 
biofilm-adapted isolates isolates, had the same effect in our system. However, a yciR 
transposon insertion mutant of B. cenocepacia H i l l (Huber et al., 2002) was defective 
in biofilm formation and quorum sensing (QS) molecule production. This mutant did not 
revert its phenotype when complemented with a functional cepR, the regulator gene of 
the CepIR QS system, leading to the conclusion that YciR is an upper-level regulator of 
the CepIR QS system. 
Though the B. cenocepacia H i l l yciR insertion mutant did not behave similarly 
to the yciR deletion mutants of Salmonella and E. coli, it is possible that the insertion 
mutation did not abolish phosphodiesterase activity of the YciR protein or to cyclic-di-
GMP pooling, whereas a complete deletion may have these effects. The transposon 
insertion in yciR in H i l l (Huber et al., 2002) may not have inactivated 
phosphodiesterase activity of yciR, depending on where in the gene the transposon 
inserted. If the transposon inserted before the EAL domain, the downstream portion of 
yciR may still have been translated if there is a strong promoter associated with the 
transposon and no translational stop codon. Maintained phosphodiesterase function of 
yciR may explain the conflicting phenotypes observed between B. cenocepacia H i l l and 
mutants in other bacteria. 
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To show that the loss of yciR affected biofilm production, I genetically 
complemented six isolates, three from 450 generations and three from 1500 
generations of biofilm adaptation, to evaluate the effects on biofilm and related 
phenotypes (colony morphology, motility, fitness in a biofilm evolution environment). I 
found that providing an intact copy of yciR in trans alters many phenotypes of the 
evolved colony morphology variants, the most obvious of these being the loss of the 
wrinkly colony phenotype of the W450 mutant. Interestingly, this is the one isolate that 
retained the yciR gene. 
Though W 4 5 0 has retained the yciR gene, it may not have retained the yciR gene 
function. I plan to fully sequence yciR in W450 to determine if function may be altered 
due to a mutation within the gene itself. It is puzzling that providing an intact yciR in 
trans in this isolate had the most dramatic effects on colony morphology, biofilm, and 
fitness in the biofilm evolution environment. If the gene is not mutated, another way to 
determine if the isolate expresses yciR would be to perform expression studies, such as 
reverse transcription-PCR, to show that the gene is not being expressed in the mutant 
(Chan and Chua, 2005). 
I chose to evaluate effects of the complementation vector on QS molecule 
production of the biofilm-adapted mutants because YciR is thought to be an upper-level 
regulator of the cep QS system (Huber, et al., 2002) and because initial data (S. Poltak, 
personal communication) suggested that the biofilm-adapted mutants were defective 
either in sensing or production of the QS signal. It is interesting that introducing the 
complementation vector into WT HI2424 did not induce increased relative C8-HSL. 
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Since the yciR mutant in B. cenocepacia H i l l (Huber et al., 2002) abolished QS molecule 
production, additional yciR in HI2424 should have an opposite effect, if the functions are 
equivalent, and increase C8-HSL QS molecule production. Since I did not observe 
increased relative QS molecule production in WT HI2424 containing the 
complementation vector, pyciRcom, it seems that YciR either does not have the same 
function in strain HI2424 as in H i l l or that the initial, limited characterization of 
function in strain H i l l was incorrect. It is interesting that introducing the 
complementation vector actually reduced relative C8-HSL production in the W isolate 
from 450 generations and the S isolate from 1500 generations. Perhaps other 
mutations acquired by these generations exert epistatic effects on QS in the biofilm-
adapted isolates or perhaps YciR truly does not function as previously thought. To 
better show that the reporter assay I adapted to determine relative increase of C8-HSL 
is a legitimate assay for this purpose, it would be necessary to create a standard curve of 
fluorescence intensity relative to known concentrations of C8-HSL as well as isolating 
HSLs rather than using conditioned medium. 
It is also critical, for all isolates, to measure the intracellular levels of cyclic-di-
GMP to determine if pooling of this secondary messenger correlates with the observed 
biofilm phenotypes, as has been observed previously in P. aeruginosa, E. coii, Vibrio, and 
Salmonella (Kulasekara et al., 2005, Garcia et al., 2004, Tischler and Camilli, 2005, 
Weber et al., 2006). We will perform this measurement via either TLC with 
radiolabeled P32 (Hickman et al., 2005) or MALDI-TOF Mass Spectrometry analysis on 
HPLC-purified nucleotides (Simm et al., 2009). 
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I predict that quantitation of cyclic-di-GMP levels in S,R, and W will show that 
each has greater concentration than the ancestral strain, with the S isolate having the 
lowest pool of the di-nucleotide of the three and R and W having highest cyclic-di-GMP 
concentrations. This prediction is supported by the fact that only the yciR deletion in S 
is predicted to lower levels of cyclic-di-GMP whereas R and W each have additional 
mutations in one of the wsp genes that would likely add to the pool. Perhaps the initial 
loss of yciR leads to pooling of cyclic-di-GMP, the S colony phenotype and increased 
biofilm, and the secondary mutations in wsp genes lead to increased pooling, and 
exaggerated colony wrinkling and even higher biofilm production in W and R. 
The single nucleotide polymorphisms (SNPs) in wspA and wspD in the W and R 
isolates, respectively, may lead to pooling of cyclic-di-GMP through constitutive 
phosphorylation of wspR, a diguanylate cyclase that would continue to catalyze the 
formation of cyclic-di-GMP, resulting in an abundance of this di-nucleotide. The 
proposed mechanism of the Wsp pathway, based on studies in P. aeruginosa, is shown 
in Figure 3.9. The non-synonymous SNP in wspA in the Wi500 isolate may alter the WspF 
binding site in the translated WspA protein, preventing WspF from performing its 
methylesterase activity to demethylate conserved glutamate residues and thereby 
shutting down the Wsp system. Without the balancing function of WspF activity, the 
methyltransferase, WspC, will constitutively methylate WspA and cyclic-di-GMP will be 
constitutively produced (Guvener and Harwood, 2007; Bantinaki et al., 2007). I predict 
that the non-synonymous SNP in wspD in the Ri50o isolate may alter the WspA protein 
because the two are closely associated and would deny WspF access to its binding 
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Figure 3.9: Model for the Function and Regulation of the Wsp Chemosensory Pathway 
The proposed mechanism of cyclic-di-GMP production by the Wsp pathway in B. cenocepacia 
based on the pathway in P. aeruginosa (adapted from Guvener and Harwood, 2007; Bantinaki et 
al., 2007), which is analogous to the Che pathway in E. coli. WspA is a predicted membrane-
associated methyl-accepting chemotaxis protein; WspC is a predicted methyltransferase that 
methylates conserved glutamate residues on WspA. WspF is a predicted methylesterase with a 
CheY-like response regulator domain. When phosphorylated, WspF removes methyl groups 
from WspA. WspB and WspD are scaffold proteins. WspE is a histidine kinase that 
autophosphorylates when WspA becomes methylated, transferring phosphate groups to WspR, 
a diguanylate cyclase (DGC) with a response regulator domain. The activated DGC causes two 
molecules of GTP to combine and form cyclic-di-GMP. WspE also transfers a phosphate group 
to WspF, which demethylates WspA and 'turns off ' the Wsp pathway. WspC constitutively 
methylates WspA (in Pseudomonas). If there is a defect in WspF methylesterase activity then 
the pathway remains 'on' and WspE continues to activate WspR, resulting in pooling of cyclic-di-
GMP. The SNP in wspA in W1500 may affect the predicted binding site of WspF in the amino acid 
sequence, preventing WspF from 'shutting off ' the pathway. Likewise, the SNP in wspD in Ri500 
may alter the protein structure enough that WspF cannot 'f ind' its binding site on WspA to 
demethylate the glutamate residues. 
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site on WspA, producing a similar predicted effect as the wspA mutation in W1500. 
Future work to continue this research will involve creation of a yciR deletion in 
the HI2424 ancestral background to evaluate effects of this single mutation on biofilm 
formation, motility and fitness in the biofilm evolution environment. Epistatic effects of 
additional mutations at both 450 and 1500 generations may mask or enhance the 
phenotypes of the loss of yciR. The evolved isolates from 1500 generations have almost 
certainly acquired more mutations than those at 450 generations because populations 
remained under strong selection to adhere to the bead and exhibit enhanced fitness in 
the selective environment (S. Poltak, personal communication). The more additional 
mutations that have accumulated, the more likely it is that epistatic effects of these 
mutations will contribute to the increased biofilm phenotypes in concert with the 
original mutation. 
In addition, I propose creating mutations in wspA and wspD of the ancestral 
clone to evaluate their effects on biofilm fitness individually and also to complement the 
evolved isolates with functional copies of either wspA or wspD. 
I propose that the initial loss of yciR is a key mutation along the path to biofilm 
adaptation. Though one isolate at 450 generations still has a yciR gene; by 1500 
generations the loss of yciR has fixed in all three isolates. This lends support to the 
hypothesis that the yciR deletion gives evolved isolates a fitness advantage in the 
biofilm evolution environment since isolates with this mutation prevail and rise to high 
frequency by 1500 generations. 
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Though the yciR deletion may be an important adaptive mutation, it is not the 
only adaptive mutation that may occur predictably in a biofilm-selective environment in 
the transition from a planktonic (acute) to a biofilm (chronic) lifestyle. However, 
mutations in three genes linked to cyclic-di-GMP turnover in three separate evolved 
isolates lend support to the hypothesis that cyclic-di-GMP pooling is a key adaptive 
mutation in our system. 
There are several drawbacks to my genetic complementation approach that 
must be considered when making conclusions about the function of yciR in B. 
cenocepacia HI2424. One drawback is that we do not know the full genetic background 
of the biofilm-adapted isolates from 450 generations of evolution and can only 
speculate on the other mutations that have fixed at this timepoint. Genotyping of 
isolates from this t ime point is ongoing and full genome sequencing is on the horizon for 
these mutants. We also do not know whether the yciR gene present in the W isolate 
from 450 generations is functioning; the first step would be a complete sequence of this 
gene. Though I cloned enough of the yciR gene that I should have captured its promoter 
region, I also directionally cloned the gene into pBBRlMCS to create the 
complementation vector pyciRcom. One consequence of the cone construction is that 
the lac promoter within pBBRlMCS may constitutively express yciR, leading to 
anomalous phenotype results. I saved constructs of yciR in pBBRlMCS that have the 
gene in the opposite direction and it would be interesting to test these for 
complementation in the biofilm-evolved isolates. 
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In conclusion, we believe that adaptation to the laboratory biofilm selective 
environment parallels adaptation to the cystic fibrosis lung. Indeed, mutations leading 
to cyclic-di-GMP pooling have been identified in clinical lung isolates of P. aeruginosa 
(Starkey et al., 2009; Smith et al., 2006). If cyclic-di-GMP pooling also occurs predictably 
in Burkholderia clinical lung infections, allowing B. cenocepacia to persist in the lung and 
continue to contribute to lung damage and functional decline, pathways of cyclic-di-
GMP synthesis would be a target for novel therapeutics. The more we know about the 
genes and mechanisms that are altered in adapting to a biofilm or chronic lifestyle, the 
better prepared we may be to combat biofilm-associated infections through novel 
therapeutics. Through our laboratory model, I have identified putative cyclic-di-GMP 
pooling as an important adaptation to the chronic biofilm lifestyle and therefore 
potential target for disruption of chronic biofilm communities. 
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Supplementary Figure 1: Scanning Electron Micrographs of 450 generation Samples obd 
Beads 
Shown are the same samples as in Figure 1 but at 10,D00X magnification. Colony pictures are 





The genus Burkholderia in general has been shown to employ quorum-sensing 
(QS) systems necessary for maximum virulence in animal host models. B. cenocepacia 
specifically employs the CepIR QS system, relying on C8-HSL, to regulate virulence and 
specific factors relevant to virulence, such as biofilm formation (Eberl, 2006). As 
reviewed in previous chapters, the YciR protein, which contains domains implicated in 
cyclic-di-GMP turnover, is thought to be an upper-level regulator exerting post-
transcriptional control over CepR. The current model of biofilm regulation centers on 
the CepIR quorum-sensing system (Figure A l ) . A functional CepIR system is required for 
biofilm formation though QS is not implicated in initial surface attachment but rather 
controls biofilm maturation (Huber et al., 2001). 
The QS molecule, C8-HSL, is produced at low levels by the Cepl synthase until 
enough C8-HSL accumulates due to cell density that a threshold concentration is 
reached and the QS molecule binds to the CepR protein which then induces or represses 
certain traits such as biofilm production and ornibactin (siderophore) production, 
respectively. The CepR-C8-HSL complex binds specifically to the cepl promoter and 
upregulates expression of cepl, producing more QS molecule (Weingart et al., 2005). 
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Figure A l : Current Mode l of Biofilm and Virulence Factor Regulation in B. cenocepacia. 
YciR is predicted to exert posttranscriptional control over the expression of CepR, which 
upregulates biofilm formation in this model, and activates transcription of cepl, producing C8-
HSL, which binds to and activates transcription of cepR. 
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Kothe et al. (2003) demonstrated that individual cepl and cepR mutants of B. 
cenocepacia strain H i l l are each attenuated in killing in a C. elegans worm model. 
Slow-killing in the C. elegans model resembles an infection-like process, which is why 
this nematode model is an accepted alternative to a mouse or cell culture model. The 
cep system also positively regulates factors associated with virulence, such as swarming 
motility, extracellular proteolytic and chitinolytic activity and represses the synthesis of 
ornibactin, the siderophore produced by B. cenocepacia (Lewenza et al., 1999; Huber et 
al., 2001; 2002; Lewenza and Sokol, 2001). 
Our strain, B. cenocepacia HI2424, is highly virulent in the C. elegans model of 
infection, more so than other strains of B. cenocepacia tested by Cooper et al. (2009), 
such as AU1054. Some strains of B. cenocepacia have additional identified QS systems, 
such as CclR, located on a pathogenicity island (Baldwin et al., 2004), though this region 
of DNA is not present in HI2424. The HI2424 strain must also have additional factors 
contributing to virulence in the worm model since it differs significantly from its close 
relatives in worm virulence (Cooper et al., 2009). It was this fact that prompted me to 
mutate cepR, which tightly regulates cepl expression (Huber et al., 2004), to determine 
if the mutant would behave similarly to strain H l l l - R (a cepR mutant) that was 
attenuated in both slow and fast killing of C. elegans (dependent on growth medium 
osmolarity). If the cepR mutant of HI2424 does not behave similarly to H l l l - R , this 
would support the existence of another functional QS system or other regulator of 
biofilm and virulence traits. 
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I predicted that the cepR mutant in HI2424 would be defective in C8-HSL 
production, biofilm formation, protease activity and worm virulence, following the trend 
of cepR mutants in other strains as reviewed above. Interestingly, not all of these 
predictions came true, suggesting another virulence regulator in HI2424 in addition to 
the CepIR system. 
Methods 
Cloning of cepR 
The wild-type cepR gene from B. cenocepacia HI2424 was cloned and inactivated 
by inserting the dhfr cassette from pFTPl within cepR. This mutant copy was then 
introduced into WT HI2424 to replace the WT gene with the mutated copy. 
The wild-type cepR gene was PCR amplified from HI2424 using the following primers: 
CepR F: 5'-GGCGAACAGCGACTTCAGCA-3' 
CepR R: 5'-GGACAGTTGCAGCACTCCGT-3' 
Cycling conditions were the same as those in the dhfr PCR screen described in Chapter 2 
except annealing was at 61°C and elongation was 3min. Amplified cepR was cloned into 
pCR®2.1-TOPO® and chemically transformed into One Shot® TOPIO Chemically 
Competent E. coli (Invitrogen). Recovered transformants were plated on LB agar 
containing 50jxg/ml Kan and IPTG and X-gal. White, Kanr colonies were used to start 
overnight liquid cultures for plasmid isolation using the QIAprep spin mini-prep kit 
(Qiagen). Cloning of the cepR gene into pCR2.1-TOPO was verified by PCR and one 
correct clone was named pCepR. 
The dhfr cassette from pFTPl was cloned into pCepR by digesting both plasmids 
with So/I (NEB). The two desired fragments were ligated with T4 DNA ligase (NEB) at a 
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3:1 insert to vector ratio (NEB), without gel purifying the dhfr cassette out of the 
digestion product. Ligation products were transformed into chemically competent E. 
coli DH5a and plated onto T-Soy agar containing 50jig/ml Tp and incubating overnight. 
Tp-resistant colonies were patched onto T-Soy containing 50[xg/ml Kan. Doubly 
resistant colonies were screened by PCR for the cepR gene with an elongation of 3min 
30sec. CepR-positive cultures were harvested for plasmid DNA as previously described 
and one correct clone was named pCepRTp. 
The suicide vector pCM42 (Tomich and Mohr, 2004) and pCepRTp were digested 
with fcoRI (NEB) and the mutated cepR was cloned into pCM42 by combining the EcoRI 
digested products at a 3:1 insert:vector ratio in a reaction with T4 DNA ligase (NEB). 
Ligation products were transformed into chemically competent E. coli DH5a X pir and 
plated onto T-Soy with 50ng/ml Tp and incubated overnight. Tp-resistant colonies were 
patched onto T Soy containing 50[xg/ml Kan or 50ng/ml Cm. Cm resistant, Kan sensitive 
colonies were screened in a cepR PCR as described previously. CepRdhfr-pos'\t\ve 
colonies were harvested for plasmid DNA using the Qiagen kit as described above and 
one correct clone was named pLCB8-84. 
cepR Inactivation in HI2424 
The suicide vector, pLCB8-84 in E. coli, was mated into Burkholderia cenocepacia 
HI2424 in a tri-parental mating with E. coli harboring the 'helper' plasmid pEVS104. For 
mating, cultures were grown overnight in liquid broth containing appropriate antibiotic. 
Cultures were mixed 2:3:3 (recipient:donor:helper) and diluted 3:1 with lOmM MgS04. 
Mating mixture was pelleted, resuspended in lOmM MgS04 and washed a second time. 
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Resuspended cells were spotted onto a filter paper square on T-Soy agar spread 
previously with lOOjxl 2M MgS04. Mating mix was incubated for 8hrs at 37°C and cells 
were harvested by vortexing the filter paper in PBS. Cells were diluted and plated onto 
T-Soy containing 15jj.g/ml polymixin B and 50jxg/ml Tp and incubated for three days at 
32°C. Resulting colonies (putative single-crossover events) were patched to T-Soy agar 
containing Cm 50pig/ml and T-Soy agar containing Tp 50pig/ml and incubated overnight. 
Cm-sensitive, Tp-resistant colonies (2nd crossover events) were screened by PCR for the 
cepR gene to determine if the wild-type cepR gene had been replaced by the dhfr-
insertion containing cepR, creating B. cenocepacia HI2424-R. Positive cultures were 
verified to be Burkholderia PCR for 16S rDNA as described in Chapter 1. 
Phenotypic Screens for cepR Knockout 
Phenotypic screens were performed on HI2424-R to determine changes to 
virulence-associated traits (virulence factors). Biofilm assays were performed as 
described in Chapter 2, in 96-well microplate format. Protease production was 
quantified by spotting 5julI of overnight culture onto milk plates (T-Soy agar, 20g skim 
milk powder/L) and measuring zones of clearing after overnight incubation. The C8-HSL 
reporter assay with P. putida F117 (pAS-C8) was also performed as described previously 
(Steidle et al., 2001) except B. cenocepacia was grown in T-Soy broth. Liquid worm 
killing assays were performed to evaluate any change in pathogenicity conferred by the 
cepR mutation as described by Cooper et al. (2009). Significance of phenotype 
differences from wild-type was evaluated by performing two-tailed t-tests assuming 
equal variance; t-test values below 0.05 were considered significant. 
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Results 
Most phenotypes of the cepR mutant, HI2424-R, that were tested were not 
significantly different from WT HI2424. However, in an initial AHL sensor assay, WT 
produces significantly more C8-HSL than does the cepR mutant (Figure A2) and protease 
production was significantly reduced versus WT (Figure A3). Worm virulence in the C. 
elegans model did not differ significantly from wild-type (Figure A4). Biofilm production 
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Figure A2: AHL Sensor Assay 
Pseudomonas putida F117 pAS-C8 sensor strain was grown overnight in the presence of fi ltered 
spent supernatant from either WT HI2424, E. colt C)P50, or HI2424 cepR mutant. The cepR 
mutant produces significantly less quorum sensing molecule as determined by lower relative 
fluorescence produced by the sensor strain than the E. coli control and the medium blank. Error 
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Figure A3: Protease Plate Assay 
The cepR mutant produced significantly less protease as determined by zones of clearing on 
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Figure A4: Liquid W o r m Virulence Assay 
Over 168 hours C. elegans worms were moni tored for % death in liquid culture that grew more 
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Figure A5: Scaled Biofilm Values for the ceoR M u t a n t and W T HI2424 
Scaled values were obtained by dividing the OD600 value of crystal violet by the OD600 value of 
the cell density after 24hr growth Error bars represent 95% confidence intervals, n=32. 
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Discussion 
A functional cepR gene does not appear to be required for virulence or for 
production of most associated virulence factors in B. cenocepacia HI2424. Though C8-
HSL production is abolished in HI2424-R, worm virulence is not affected, nor was biofilm 
production. These results contradict those found in studies of cepR mutants in other 
strains of B. cenocepacia. However, Kothe et al. (2003) performed agar medium-based 
assays of worm virulence whereas I used a liquid medium model of virulence. I also 
performed agar medium killing assays but results were too variable to draw conclusions 
about virulence. My results suggest that there may be other virulence factors or global 
regulators acting in HI2424 in addition to the CepIR QS system. 
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